Transfusion Medicine Reviews
Volume 20, Issue 3 , Pages 181-189 , July 2006

Potential Impact of Pandemic Influenza on Blood Safety and Availability

  • Shimian Zou

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Shimian Zou, PhD, Transmissible Diseases Department, Jerome H. Holland Laboratory, American Red Cross Biomedical Services, 15601 Crabbs Branch Way, Rockville, MD 20855.

References 

  1. WHO . Avian influenza and human pandemic influenza—Summary report on the avian influenza meeting held in Geneva, Switzerland in November 7-9, 2005. www.who.int
  2. WHO . Avian influenza—Current evaluation of risks to humans from H5N1 following recent reports. Wkly. Epidemiol. Rec. 2004;79:265–268
  3. Meltzer MI, Cox NJ, Fukuda K. The economic impact of pandemic influenza in the United States: Priorities for intervention. Emerg. Infect. Dis. 1999;5:659–671
  4. Dowdle WR. Influenza pandemic periodicity, virus recycling, and the art of risk assessment. Emerg. Infect. Dis. 2006;12:34–39
  5. Fauci AS. Pandemic influenza threat and preparedness. Emerg. Infect. Dis. 2006;12:73–77
  6. Kilbourne ED. Influenza pandemics of the 20th century. Emerg. Infect. Dis. 2006;12:9–14
  7. Taubenberger JK, Morens DM. 1918 influenza: The mother of all pandemics. Emerg. Infect. Dis. 2006;12:15–22
  8. Webster RG, Peiris M, Chen H, et al. H5N1 outbreaks and enzootic influenza. Emerg. Infect. Dis. 2006;12:3–8
  9. WHO . Summary of influenza activity, September 2004-August 2005. Wkly. Epidemiol. Rec. 2005;80:353–355
  10. Thompson WW, Shay DK, Weintraub E, et al. Influenza-associated hospitalizations in the United States. JAMA. 2004;292:1333–1340
  11. Zimmerman RK. Recent changes in influenza epidemiology and vaccination recommendations. J. Fam. Pract. 2005;54:S1–S8
  12. Reichert TA, Simonsen L, Sharma A, et al. Influenza and the winter increase in mortality in the United States, 1959-1999. Am. J. Epidemiol. 2004;160:492–502
  13. Simonsen L, Reichert TA, Viboud C, et al. Impact of influenza vaccination on seasonal mortality in the US elderly population. Arch. Intern. Med. 2005;165:265–272
  14. Cohen J. Influenza. Study questions the benefits of vaccinating the elderly. Science. 2005;307:1026
  15. Lipatov AS, Govorkova EA, Webby RJ, et al. Influenza: Emergence and control. J. Virol. 2004;78:8951–8959
  16. Hien TT, de Jong M, Farrar J. Avian influenza—A challenge to global health care structures. N. Engl. J. Med. 2004;351:2363–2365
  17. Ungchusak K, Auewarakul P, Dowell SF, et al. Probable person-to-person transmission of avian influenza A (H5N1). N. Engl. J. Med. 2005;352:333–340
  18. Monto AS. The threat of an avian influenza pandemic. N. Engl. J. Med. 2005;352:323–325
  19. Liem NT, et al. Lack of H5N1 avian influenza transmission to hospital employees, Hanoi, 2004. Emerg. Infect. Dis. 2005;11:210–215
  20. Kaye D, Pringle CR. Avian influenza viruses and their implication for human health. Clin. Infect. Dis. 2005;40:108–112
  21. Stegeman A, Bouma A, Elbers AR, et al. Avian influenza A virus (H7N7) epidemic in The Netherlands in 2003: Course of the epidemic and effectiveness of control measures. J. Infect. Dis. 2004;190:2088–2095
  22. Du Ry van Beest Holle M, Meijer A, Koopmans M, et al. Human-to-human transmission of avian influenza A/H7N7, The Netherlands, 2003. Euro. Surveill. 2005;10:(Electronic publication ahead of print)
  23. Nicoll A. Avian and pandemic influenza—five questions for 2006. Euro. Surveill. 2005;10:(Electronic publication ahead of print)
  24. Tweed SA, Skowroski DM, David ST, et al. Human illness from avian influenza H7N3, British Columbia. Emerg. Infect. Dis. 2004;10:2196–2199
  25. Palese P. Influenza: Old and new threats. Nat. Med. 2004;10:S82–S87(suppl 12)
  26. Guan Y, Zheng BJ, He YQ, et al. Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China. Science. 2003;302:276–278
  27. Bardiya N, Bae JH. Influenza vaccines: Recent advances in production technologies. Appl. Microbiol. Biotechnol. 2005;67:299–305
  28. Epstein S. Control of influenza virus infection by immunity to conserved viral features. Expert Rev. Anti-infect Ther. 2003;1:627–638
  29. Spier RE. On the need for, and the delivery of, cross-protective vaccines. Vaccine. 2005;23:2027–2029
  30. Monto AS. Vaccines and antiviral drugs in pandemic preparedness. Emerg. Infect. Dis. 2006;12:55–60
  31. Palese P. Making better influenza virus vaccines?. Emerg. Infect. Dis. 2006;12:61–65
  32. Thomas PG, Keating R, Hulse-Post DJ, et al. Cell-mediated protection in influenza infection. Emerg. Infect. Dis. 2006;12:48–54
  33. Gani R, Hughes H, Fleming D, et al. Potential impact of antiviral drug use during influenza pandemic. Emerg. Infect. Dis. 2005;11:1355–1362
  34. Balicer RD, Huerta M, Davidovitch N, et al. Cost-benefit of stockpiling drugs for influenza pandemic. Emerg. Infect. Dis. 2005;11:1280–1282
  35. Hampton T. Government drafts flu preparedness plan: concerns about serious pandemic spur effort. JAMA. 2004;292:1671–1672
  36. Minuse E, Willis PW, Davenport FM, et al. An attempt to demonstrate viremia in cases of Asian influenza. J. Lab. Clin. Med. 1962;59:1016–1019
  37. Stanley ED, Jackson GG. Viremia in Asian influenza. Trans. Assoc. Am. Physicians. 1966;79:376–387
  38. Khakpour M, Saidi A, Naficy K. Proved viraemia in Asian influenza (Hong Kong variant) during incubation period. BMJ. 1969;4:208–209
  39. Lehmann NI, Gust ID. Viraemia in influenza. A report of two cases. Med. J. Aust. 1971;2:1166–1169
  40. Roberts GT, Roberts JT. Postsplenectomy sepsis due to influenzal viremia and pneumococcemia. CMAJ. 1976;115:435–437
  41. de Jong MD, Bach VC, Phan TQ, et al. Fatal avian influenza A (H5N1) in a child presenting with diarrhea followed by coma. N. Engl. J. Med. 2005;352:686–691
  42. Wilson N, Baker M, Crampton P, et al. The potential impact of the next influenza pandemic on a national primary care medical workforce. Hum. Resour. Health. 2005;3:7–12
  43. Enserink M. Looking the pandemic in the eye. Science. 2004;306:392–394
  44. WHO . Nonpharmaceutical interventions for pandemic influenza, national and community measures. Emerg. Infect. Dis. 2006;12:88–94
  45. Qureshi K, Gershon RR, Sherman MF, et al. Health care workers' ability and willingness to report to duty during catastrophic disasters. J. Urban Health. 2005;82:378–388

PII: S0887-7963(06)00011-3

doi: 10.1016/j.tmrv.2006.03.001

Transfusion Medicine Reviews
Volume 20, Issue 3 , Pages 181-189 , July 2006

Article Tools